Chronic Kidney Disease

Ozempic Ingredient Gives Novo Nordisk's Kidney Trial A Positive Result: What It Means For Health Care

FDA Strikes Off Reata Pharma's Bardoxolone Application For Rare Kidney Disease

FDA Raises Concerns On Reata's Kidney Disease Drug Data; Shares Plunge

FDA Strikes Off Reata Pharma's Bardoxolone Application For Rare Kidney Disease

FDA Raises Concerns On Reata's Kidney Disease Drug Data; Shares Plunge

Why Are Vertex Pharmaceuticals Shares Trading Higher Today?

GlaxoSmithKline Spotlights Encouraging Data For Anemia Drug

Why Are Vertex Pharmaceuticals Shares Trading Higher Today?

GlaxoSmithKline Spotlights Encouraging Data For Anemia Drug

See Why Cara Therapeutics (CARA) Stock Is Moving Higher On Tuesday

FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial

Chronic Kidney Disease Recent News

Will Kidney Transplant Recipients Need Third COVID-19 Vaccine Dose? NIH Starts Pilot Study

Roth Capital Initiates Coverage On Newly Listed Unicycive

AstraZeneca's Forxiga Wins European Approval For Chronic Kidney Disease

Ardelyx's Tenapanor Application For Chronic Kidney Disease Receives FDA Response Letter

Ardelyx Stock Collapses After FDA Rejects Its Kidney Disease Candidate Pitch

DiaMedica Therapeutics Stock Slips On Mixed DM199 Data In Chronic Kidney Disease Patients

OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China

Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related Anemia

Ardelyx Stock Plummets As Review Period For Tenapanor US Application Pushed By 3 Months

FibroGen Stock Is Trading Lower As CEO Admits Manipulated Safety Data For Roxadustat

Reata Pharma Shares Are Trading Higher After Filing US Application In Alport Syndrome-Related Kidney Disease

Reata Pharmaceuticals Inc (NASDAQ: RETA) has

Evotec, Chinook Therapeutics Ink Development Pact For Chronic Kidney Diseases Therapies

Chinook Therapeutics Inc (NASDAQ: KDNY) and Evotec SE (OTCMKTS: EVTCY) have

Keryx Biopharmaceuticals Surges 20% Following Positive Kidney Disease Drug Data

Why Shares Of Rockwell Medical Are Up Huge